Introduction
Obesity is one of the global health issues. Imbalance between lack of physical activities and excessive nutrition intake cause metabolism disorder and visceral fat accumulation which lead to adipose hypertrophy, particularly in abdomen. 1 Adipose hypertrophy could stimulate the production of various proinflammatory cytokines, which spread into other tissues, such as liver and muscles that trigger the insulin resistance (IR). 2 IR is a physiological condition where target organs, including skeletal muscle, adipose tissue, and liver cell fail to respond insulin action effectively. Sistemic insulin resistance in obesity begins mostly in adipose tissue disfunction through macrofagmediated inflammation. Adipose tissue can communicate with liver and other organs such as liver muscle and pancreas, and releases proinflammatory cytokines which cause decreased insulin sensitivity.
Progress of type 2 diabetes mellitus (T2DM) in obese individual begins with beta cell disfunction induced by insulin resistance and lipotoxicity so that it decreases insulintropic GLP-1 action. 4 Measurement of insulin resistance using Homeostasis Model Assesment (HOMA) approach has been developed to show the balance between hepatic glucose production and beta cell insulin secretion under basal homeostasis. HOMA-IR is used to measure insulin resistance index that is obtained from calculation of fasting insulin concentration x fasting glucose/22.5.
5,6
Insulin resistance is not only caused by carbohydrate and fat metabolism disorders, but also protein. 7 Some metabolomic studies have been done to identify new biomarker associated with insulin resistance that has prediabetes prediction value and T2DM, such as branched chain amino acids including leucine. Compared with the other amino acids, leucine indicates the highest insulinogenic index so that it plays important role in mTORC-1 regulation, beta cell growth, beta cell proliferation and insulin secretion. Activation of mTORC-1 depends on adequate supply of branched chain amino acids especially leucine. 8 Leucine acts as nutrient signal, managing protein synthesis, and degradation and secretion of insulin as potential Mammalian Target of Rapamycin Complex-1 (mTORC-1) activator and increased glucose uptake through phosphorylation Akt in adipose tissue.
So as early stage, this premilinary experiment was conducted to see the correlation between leucine for diabetes risk early detection and insulin resistance (HOMA-IR) in central obese men.
Leucine is one of the amino acids containing more than 20% of total protein food. At physiological concentration, leucine regulates gen transcription and protein synthesis in pancreatic beta cell through either dependent pathway or independent pathway in mTORC-1.
8 Leucine's role in insulin resistance pathogenesis as marker that energy metabolic pathways disorder has occured. 9 There is an excessive energy in obesity that will cause expression change and decreased activity of leucine metabolic enzyme that is BCATm in adipose tissue so that decreased leucine catabolism occurs and leucine increases in circulation. 10 Change in metabolism pathway occured by increased leucine concentration causes gluconeogenesis, that is glucose production of amino acids in liver. High concentration of glucose from gluconeogenesis will increase signal so that pancreas secretes insulin continously and causes IGF-1 activates mTORC-1. Hyperactivity of mTORC-1 will activate p70 ribosomal S6 kinase (p70S6K) then serine phosphorylation takes place and resists insulin-1 receptor substrate (IRS). This condition will disrupt insulin signal and causes IRS-1 degradation so that insulin resistance occurs.
Methods
This experiment was a prospective cross sectional study conducted at Prodia Clinic Laboratory Semarang, Bandung, Bogor, and Jakarta. This experiment was approved by Health Research Ethics Committe, Faculty of Medicine, Padjajaran University, with No. 3577/UN6.O.1/LT/2017. Informed consent was obtained from each subject. Included subjects were 60 male adults aged 30-50 years old, with abdominal circumference >90cm for central obesity group according to WHO criteria for regional Asia Pasific and 20 subjects with abdominal circumference <90cm as control group.
Sample preparation
One tube (9 ml) of subjects' blood was taken from blood vessel in the elbow crease. SGOT, SGPT, creatinine, hsCRP, HbA1c, fasting blood glucose, insulin and leucine were measured. Subjects' blood was taken by using venipuncture technic by professionals. The blood in the SST tube then were kept for 30 minutes until cloted then were centrifuged (3000 RPM) for 15 minutes. The serum was aliquoted according to the examination type and was kept on temperature -70°C for analysis. Blood sample taken using tube with anticoagulant EDTA then were inverted (approximately 10 times) to ensure anticoagulant and the blood were perfectly mixed.
Measurement of leucine concentration
10 uL leucin (100 umol/L) as the internal standard was mixed with 100 ml serum. It was then homogenized using vortex for 30 seconds. 900 uL methanol LC-MS grade were added until protein sediment was formed. The mixture then was homogenized for 2 minutes then was centrifuged (14000 rpm) for 10 minutes. 100 uL supernatant was added with 500 uL methanol (50%) and were homogenized for 1 minute. The sample was then examined using LC-MS system. The examination has been developed and validated by Laboratory Mass Spectrometry PT. Prodia Widyahusada, Tbk.
Data analysis
T-test and correlation Pearson test was used to evaluate the correlation between leucine concentration and insulin resistance (HOMA-IR). Analysis was calculates using SPSS 24 Significance level was set at 5%.
Results and Discussion
In this preliminary research, 80 subjects consisting of 20 non-central obese men as control and 60 central obese men were included (Table 1) . Increased leucine concentration in central obesity is in line with the mechanism in the progress into insulin resistance and DM. In obesity, there is expression change and decreased activity of enzyme transaminase in adipose tissue so that decreased leucine catabolism causes increased leucine in circulation. 7 This condition causes change of metabolism pathway that is increased gluconeogenesis which is the signal for pancrease to increase insulin secretion and to activate mTORC-1. Hyperactivity of mTORC-1 activates p70S6K which cause serine phosphorylation and retardation of insulin-1 receptor substrate (IRS). This condition will disrupt insulin signal and IRS-1 degradation so that insulin resistance occurs. 9, 10 This research can be a start point for further research regarding determination of cutoff value of leucine concentration in central obese men to predict and evaluate the risk of insulin resistance.
Conclusion
Leucine concentration in central obese men group significantly correlates with insulin resistance (HOMA-IR). The higher leucine concentration, the higher the risk of insulin resistance occurrance. Leucine can be used for early detection of insulin resistance.
